US 6,091,973 AGrant
Monitoring the Occurrence of Apneic and Hypopneic Arousals
Issue Date:2000-07-18
•16 Claims
•5 Drawing Sheets
Abstract
The occurrence of an arousal in a patient associated with an apneic or hypopneic episode can be determined. Sensors are placed on a patient to obtain signals representative of at least two physiological variables, for example skin conductance, heart rate, and blood oxygen concentration. The signals are conditioned by conditioning circuitry, then processed by a processor to correlate at least two thereof. A coincident change in at least two of the processed signals is indicative of the occurrence of an arousal, that in turn indicates an apneic or hypopneic episode has occurred. A patient thus can be diagnosed as suffering conditions such as obstructive sleep apnea.
Metadata
Assignee
- ResMed Limited
Inventors
- Gregory Alan Colla
- John William Ernest Brydon
Application Information
Application Number:US 8940932
Filing Date:1997-12-22
Priority Date:1995-04-11
Art Unit:376
Classifications
IPC:
A61B 500
Field of Search:
600306;324;483;484;529;547
Patent Drawings (5 sheets)
Description
Field of the Invention
This invention relates to methods and apparatus for the determination or monitoring of arousals that are indicative of an apneic or hypopneic episode. An "A/H episode", as used hereafter, is to be understood as including both obstructive apneas (lack of breathing) or hypopneas (reduction in breathing) occurring during sleep.
Background of the Invention
People suffering from Obstructive Sleep Apnea (OSA) and related conditions experience many A/H episodes during sleep. The conventional treatment for OSA is the well known Continuous Positive Airway Pressure (CPAP) treatment. An A/H episode often has an associated arousal, which is a nervous system response to low blood oxygen level and/or high blood carbon dioxide level.
The condition of OSA normally is diagnosed by laboratory based polysomnography (PSG). PSG involves the measurement of sleep and respiratory variables including EEG, EOG, chin EMG, ECG, respiratory activity, nasal airflow, chest and abdominal movements, abdominal effort and oxygen saturation. The data gathered leads to a calculation of the Respiratory Disturbance Index (RDI) which is the average number of arousals per hour due to respiratory disturbance. PSG is uncomfortable for a patient due to the placement of numerous electrodes on the patient's head or face and the wearing of a mask or nasal prongs. PSG is an expensive procedure and has the inconvenience of requiring the patient to attend a sleep clinic for a whole night requiring continuous technician attendance.
In the clinic, cortical arousals can be detected by measuring and interpreting, either automatically or by eye, changes in the patient's EEG and EMG. Arousals are an important indicator of the amount and quality of sleep obtained by a patient and the degree of severity of the patient's apneas.
To obtain a display of the EEG, electrodes must be attached to the patient's head and the signals from these electrodes passed through high gain amplifiers before subsequent display and recording. This is often inconvenient and time consuming; the signals also can become distorted or disappear due to electrode dislodgement or other artefacts such as sweating. To detect an arousal, the EEG, once displayed, requires interpretation either visually by a skilled operator or automatically by a computer-based analysis system. Apart from the difficulties of attaining accurate EEG data, EEG apparatus also is relatively more expensive than much other biomedical apparatus.
EEG data on its own is not an accurate determination of the occurrence of A/H episodes--an arousal can be due to other factors as noted.
Prior art disclosures that form background information to the present invention include (a) R. Ferber, et al, "ASDA Standards of Practice--Portable Recording in the Assessment of Obstructive Sleep Apnea", Sleep, 17(4): 378-392, 1994; (b) L. Ferini-Strambi, et al, "Heart rate variability during sleep in snorers with and without obstructive sleep apnea", Chest, 102(4): 1023-7, October 1992; and (c) C. Guilleminault, et al, "A review of 50 children with obstructive sleep apnea syndrome", Lung, 159:275-287, 1981.
Summary of the Invention
It is an object of the present invention to overcome or at least ameliorate one or more of the problems with the prior art. In one preferred form the invention seeks to provide a method and apparatus for monitoring the occurrence of arousals due to A/H episodes. The invention in another broad form has as an object the determination of an index of sleep quality that can be used as a diagnostic indicator of a person suffering from conditions such as OSA. Yet further, the invention has as an object the provision of diagnostic apparatus for the recording the occurrence of A/H episodes. A preferred embodiment particularly contemplates detecting sympathetic arousals indicative of A/H episodes by signals derived from a patient which are easier to detect than by EEG, and by use of apparatus that is less costly than that for EEG.
It has been determined that the coincident occurrence of change in the sympathetic physiological variable of sweating and another physiological variable, or of a change in at least two sympathetic physiological variables not necessarily including sweating, is indicative of an arousal associated with an apneic or hypopneic episode.
Therefore, the invention discloses apparatus for monitoring the occurrence of arousals associated with apneic or hypopneic episodes, the apparatus comprising: sensor means for obtaining two or more signals from a patient, one signal representative of skin conductance and the other signals each representative of a physiological variable; and means for correlating said skin conductance signal and at least one other said signal, a coincident change in at least said skin conductance signal and said at least one other said signal being indicative of the occurrence of an arousal.
The correlation can be other than a correlation in the strict mathematical sense, including coincident visual inspection, logical ANDing, indicator voting or weighted sums relative to a threshold.
Preferably, the sensor means comprises electrodes attachable to a patient's body. The signals derived from the electrodes can be signal-conditioned. Furthermore, the means for correlating includes data processing means. Each said signal can have an associated confidence level so that a weighting can be applied in the correlation.
The invention further discloses a method for monitoring the occurrence of arousals associated with apneic or hypopneic episodes, the method comprising the steps of: obtaining two or more signals from a patient, one signal representative of skin conductance and the other signals each representative of a physiological variable; correlating the skin conductance signal and at least one other said signal; and determining whether a coincident change in at least said skin conductance signal and said at least one other signal occurs as an indication of the occurrence of an arousal.
The changes in physiological states can include reduction in blood oxygen saturation, change in heart rate, change in skin conductance, change in skin temperature, increase in blood pressure and changes in breathing sounds.
The invention further discloses apparatus for the diagnosis of apneic or hypopneic episodes resulting in arousals, the apparatus comprising: sensor means for obtaining from a patient two or more signals, each signal representative of a physiological variable and including skin conductance; and means for correlating said two or more signals, one or more coincident changes in at least said skin conductance signal and one other said signal being indicative of an arousal associated with an apneic or hypopneic episode.
The invention yet further discloses a method for the diagnosis of apneic or hypopneic episodes resulting in arousals, the method comprising the steps of: obtaining two or more signals from a patient, each signal representative of a physiological variable and including skin conductance; storing said signals as a time sequence; following completion of obtaining said signals, correlating said two or more signals; and determining whether a coincident change in at least said skin conductance signal and one other said signal occurs as an indication of the occurrence of an arousal associated with an apneic or hypopneic episode.
The invention yet further discloses apparatus for the acquisition of data from a patient from which the diagnosis of apneic or hypopneic episodes resulting in arousals can be made, the apparatus comprising: sensor means for obtaining from the patient two or more signals, each signal representative of a physiological variable and including skin conductance; and a memory for storing said signals in a time sequence for subsequent correlation.
The invention yet further discloses a method for the determination for a patient of an index of sleep quality, the method comprising the steps of: obtaining two or more signals from the patient, each signal representative of a physiological variable; correlating said two or more signals; and recording instances where there is a coincident change in said correlated signals, the number of instances of coincidence being proportional to said index.
The invention yet further discloses apparatus for monitoring the occurrence of sympathetic arousals associated with apneic or hypopneic episodes, the apparatus comprising: sensor means for obtaining two or more signals from a patient, each signal representative of a sympathetic physiological variable; and means for correlating said two or more signals, a coincident change in at least two of said signals being indicative of the occurrence of a said arousal.
The invention yet further discloses a method for monitoring the occurrence of sympathetic arousals associated with apneic or hypopneic episodes, the method comprising the steps of obtaining two or more signals from a patient, each signal representative of a sympathetic physiological variable; and correlating said two or more signals whereby a coincident change in at least two of said signals is indicative of the occurrence of a said arousal.
Embodiments of the invention have the advantage of being non-invasive. This is of particular importance when diagnosis of conditions such as OSA must be undertaken on a baby or small child who may be disturbed by the conventional PSG apparatus.
One embodiment, relating to apparatus for the acquisition of data from which the diagnosis of apneic or hypopneic episodes, and thus the likelihood of the presence of conditions including OSA exist in a patient, can, in the first instance, substitute for a conventional sleep study and allow a candidate to collect data when in the home in a non-invasive manner. The data then can be analysed by a medical practitioner and a determination made of whether further detailed investigations need to be conducted.
Brief Description of the Drawings
FIG. 1 is a schematic block diagram of diagnostic apparatus embodying the invention;
FIG. 2 is a schematic block diagram of a circuit for measuring skin conductance;
FIG. 3 is a plot of skin conductance with time;
FIG. 4 is a plot of skin conductance together with airflow rate, heart rate and SaO.sub.2 ; and
FIG. 5 is a plot of skin conductance measured periodically both before and during CPAP treatment is implemented.
Description of Preferred Embodiments
The sequence of events leading to an arousal due to an apnea or hypopnea are as follows:
1. The patient's upper airway obstructs as they try to inspire, or the central nervous system drive to breathe is inhibited and the patient makes no effort to breathe.
2. The oxygen level in the patient's arterial blood begins to fall and the carbon dioxide level rises.
3. After some time, which may exceed a minute, blood gas sensitive receptors in the carotid and/or aortic arteries force an arousal causing the patient to partially wake and recommence breathing.
This sequence is associated with a number of physiological changes (apart from those of the EEG referred to above) some of which are driven by the sympathetic nervous system which can be monitored:
1. A fall in blood oxygen saturation (SaO.sub.2) with subsequent post-apneic rise. SaO.sub.2 can be measured by pulse oximetry.
2. A decrease in heart rate as the patient's hypercapnia increases, followed by an increase when they arouse and restart breathing. Heart rate can be measured by ECG techniques.
3. A change in skin conductance due to sweating, measured by application of an electrical potential to measure conductance/impedance.
4. Increase in blood pressure. Blood pressure can be measured by continuous sphygomomanometry.
5. Change in constriction of blood vessels in the skin leading to a change in skin temperature and a change in tissue volume, particularly that in the fingers. This can be measured by plethysmography.
6. A reduction in breathing sounds as the apnea occurs followed by a snore or snort when the apnea is broken.
Taken separately, each of the above changes is only ambiguously related to an arousal after an obstructive event. Each also is subject to artefacts in the signal which are a function of how it is measured. However, by combining several of the above measurements, a much more artefact-free and specific diagnostic indicator of an arousal due to an A/H episode can be obtained.
FIG. 1 shows a plurality of sensors 10.sub.1 -10.sub.n from which signals of the type described above are obtained from the patient. The sensors typically will comprise a sensing portion to detect physiological functions such as blood oxygen saturation, heart rate, skin conductance, blood pressure, skin temperature and audible noises, coupled with amplifying/buffering devices to derive an electrical signal.
The electrical signals each are passed to a corresponding preprocessing section 12.sub.1 -12.sub.n. The conditioning typically can include averaging, thresholding linearisation and differentiation for those signals which exhibit a marked change. Each of the n signals has a characteristic pattern or range of patterns associated with apneic and hypopneic events. Each matching pattern serves as an indicator for an apneic or hypopneic event. A characteristic pattern for each signal is as follows.
1. The blood oxygen saturation signal (SaO.sub.2) is low-pass filtered, resulting in a baseline value. Signal values which differ from the baseline by a predetermined threshold, typically 3%, are positive indicators.
2. The heart rate signal is low-pass filtered to remove high frequency components, including the sinus rhythm. This signal is then differentiated, so that changes in the heart rate are evident. A fall in the heart rate followed by a marked increase in heart rate is an indicator. When the difference between the slowest and fastest heart-rate is greater than a specified minimum, typically 20 beats per minute, the indicator scores positively.
3. The skin conductance is low-pass filtered, resulting in a baseline value, then is high-pass filtered to accentuate changes. When the conductance increases above a specific ratio of the baseline, typically 100%, the indicator scores positively.
4. The blood pressure signal (both systolic and diastolic) is low-pass filtered to produce a baseline value. The elevation of the blood pressure by more than a predetermined threshold, typically 25%, results in a positive indicator.
5. The skin temperature is low-pass filtered to produce a baseline value. If the skin temperature falls below a specific threshold from the baseline, typically between 0.5 and 1.0.degree. C., the indicator is positive.
6. Breathing sounds are band-pass filtered, typically between 30 and 300 Hz. The energy from this signal is estimated by squaring or rectifying the filtered signal, and is used as a measure of snore intensity. A significant fall in the snore intensity, typically by 6 dB, followed by a sharp increase, is a positive indicator.
The conditioned signals 14.sub.1 -14.sub.n, together with a quality signal 16.sub.1 -16.sub.n giving a measure of the quality (confidence) of the signal, are passed to a multi-input processing device 18. The multiple input signals are processed algorithmically, with ones of the signals 14 having the higher quality factor being given more weight.
The detection of an isolated matching pattern does not signify an apneic or hypopneic event. However, the coincidence of two or more of these indicators increases the confidence of event detection. Various algorithms can be used:
1. Indicator ANDing, whereby each of the indicators must be positive to indicate an arousal.
2. Indicator voting, whereby most of the indicators must be positive to indicate an arousal.
3. Weighted sum, whereby each of the indicators has a predetermined weight. The products of each indicator and its weight are accumulated. The sum indicates an arousal if the sum is above a predetermined threshold.
The processing device 18 thus makes a determination of whether an arousal associated with an A/H episode has occurred, and further determines the percentage chance that this `diagnosis` is correct, and yet further provides a determination of the duration of the A/H episode that preceded the arousal. These determined functions are logged to a memory device 20 for subsequent analysis, for example by plotting with time and observing coincidences, and also can be indicated on a display device 22 in real time.
From this information an index of arousals can be compiled, typically as arousals per hour, providing an alternative indicator to ROI, as previously discussed, to serve as a useful indicator of sleep quality.
In another embodiment the signals obtained from the sensors can be directly stored in the memory device 20 in a time sequence for subsequent correlative processing by the processing device 18, or by a processor independent of the data acquisition module. This embodiment can serve as a data acquisition device for home usage, with the correlative processing occurring at a medical practitioner's surgery (for example) at a later time.
Particular embodiments now will be described, relating to clinical measurements performed on three patients, and for which the physiological variables measured include skin conductance and heart rate (particularly cardiac rate, both of which are sympathetic variables).
Heart rate is measured by a conventional technique, namely three lead ECG. It is preferred that the electrodes are located at the patient's body's extremities to avoid apprehension and reduce the likelihood of unwanted artifacts due to gross body movement.
The skin conductance measurement similarly is performed at the body's extremities, in one case being on the sole of a foot where sweat glands are concentrated. An alternate site is the forehead. Skin conductance is to be understood as the reciprocal of skin resistance, which is affected by sweating. In the complex number domain, conductance is the real part of skin admittance. As follows, skin also exhibits a reactive property (essentially a capacitance), the reciprocal of which is the susceptance.
FIG. 2 shows a schematic block diagram of a skin conductance measurement system 30 representing one form of a sensor 10 and preprocessing section 12. An oscillator 32 applies a 1 kHz signal of approximately 0.6 V.sub.pp signal between two electrodes placed apart on the sole of the patient's foot, thereby applying an excitation to the patient's skin 34. The current passing through the electrodes is dependent upon the conductance and susceptance of the skin and interconnecting tissue.
A sense resistor 36 converts the current to a signal voltage c.sub.S, which is amplified by an amplifier 38. A demodulator circuit 40,42 removes the effects of the skin susceptance (i.e. due to the skin's capacitance) from the amplified signal C.sub.S, so that the resulting signal, SCL, is proportional to the skin conductance (level). The baseline of the SCL is removed by a high pass filter 44 and amplified (not shown) so that responses to arousals are accentuated and more easily monitored. The resultant signal, SCR, is indicative of the skin conductance response.
FIG. 3 shows a time window of one half an hour during a sleep study performed on a patient known to be a sufferer of Obstructive Sleep Apnea. The upper trace represents the skin conductance SCL, and the lower trace the skin conductance response SCR. The sensed response at approximately t=267.5 minutes corresponded with an apneic arousal otherwise determined by PSG. Skin conductance thus is a reliable partial indicator of an arousal associated with an A/H episode.
FIG. 4 shows an excerpt from a sleep study conducted on a different patient showing a relevant 30 minute window. The patient is a known sufferer of OSA. The uppermost trace is heart rate filtered over one minute to remove sinus rhythm. The units are beats per minute, and the measurement is made with a pulse oximeter. The second trace (in descending order) is blood oxygen saturation (SaO.sub.2) also measured with a pulse oximeter. The scale is 0-100%. The third trace is the SCR phase reference signal and the fourth trace the SCL base reference signal as measures of skin conductance. The units of conductance are relative only. The lowermost trace is of respiratory airflow measured with nasal cannulae and a pressure transducer.
FIG. 4 shows a continuous decrease in nasal airflow until approximately t=11 minutes corresponding to a hypopneic event. At this point nasal airflow increased with the taking of a sudden deep breath. The SaO.sub.2 trace shows a corresponding fall of approximately 5%, which, because of heavy filtering, appears after the resumption of normal breathing, although in fact was coincident with the sudden deep breath. The chain of events was shallow breathing (hyponea), followed by a fall in SaO.sub.2, followed by a resumption of normal breathing. Associated with the arousal causing the resumption of normal breathing is tachycardia, with the heart rate increasing by about 20 bpm. The arousal is coincident in time with the sudden increase in skin conductance and heart rate. Thus these two quantities can be utilised in concert as an indicator of arousals associated with A/H episodes.
Interestingly, at approximately t=20 minutes, there is a sudden interruption in respiratory airflow as a result of the patient sighing, however there is no corresponding indicator in either skin conductance or heart rate to suggest that the cessation of flow was due to an apnea.
The data indicates that the correlation of skin conductance with one or more other physiological variables (whether associated with the sympathetic nervous system or not) or any two or more sympathetic physiological variables (for example blood pressure and heart rate), is an accurate determinant of the occurrence of an arousal associated with an A/H episode. Further, it is believed that the correlation of two sympathetic physiological variables, not necessarily including skin conductance, and for example heart rate and blood pressure, also is an accurate determinant.
FIG. 5 shows a plot of the variance of skin conductance for the third patient during a sleep study in which between t=20:30 hours and t=1:15 hours no CPAP treatment was in place, and between t=1:15 hours and t=5:30 hours CPAP treatment was in place. The sampling points are at five minute epochs. The 10 and 90 centiles have been shown. The plot indicates the reduction in variance of skin conductance both before and after the commencement of CPAP treatment as an indication of the reduction in the number of arousals due to A/H episodes and thus the reliability of skin conductance as a partial indicator of A/H episodes.
In summary, embodiments of the invention can serve to monitor the occurrence of apneic or hypopneic episodes, to diagnose the occurrence of A/H episodes resulting in arousals, to acquire data from which the diagnosis of A/H episodes resulting from arousals can be made, to determine an index of sleep quality, and to monitor the sympathetic nervous system.
Claims
We claim:
1. An apparatus for monitoring the occurrence of arousals associated with episodes selected from the group consisting of apnea and hypopnea, the apparatus comprising: sensor means for obtaining at least two signals from a patient, one signal representative of skin conductance and the other signals each representative of a physiological variable; and means for correlating said skin conductance signal and at least one of said other said signals, said correlating means monitoring a coincident change in said correlated signals, said change being indicative of the occurrence of an arousal.
2. The apparatus as claimed in claim 1, wherein said means for correlating includes a data processor for receiving and analysing said signals.
3. The apparatus as claimed in claim 2, wherein said data processing means analyses said signals by a mathematical correlation, selected from the group of logical ANDing, indicator voting, weighted sums relative to a threshold and any combination of said foregoing mathematical correlations.
4. The apparatus as claimed in claim 3, further comprising a memory for storing said signals for analysis and for output to an output device.
5. The apparatus as claimed in claim 4, further comprising an indicator coupled to said data processing means, and giving a visual indication of the occurrence of an arousal.
6. The apparatus of claim 4, wherein said output device is a visual display.
7. The apparatus as claimed in claim 1, wherein said other signals are representative of a physiological variable and are selected from the group consisting of blood oxygen saturation, heart rate, skin temperature, blood pressure, breathing sounds and any combination of the foregoing physiological variables.
8. The apparatus of claim 1, wherein said sensor means obtain signals representative at least of the patient's skin conductance and cardiac rate.
9. A method for monitoring the occurrence of arousals associated with apneic or hypopneic episodes, the method comprising the steps of: obtaining at least two signals from a patient, one signal representative of skin conductance and at least one of said other signals representative of a physiological variable, correlating the skin conductance signal and said at least one other said signals, and determining whether a coincident change in said correlated signals indicates the occurrence of an arousal.
10. A method as claimed in claim 9, whereby said step of correlating includes a process of mathematical correlation, selected from the group consisting of logical ANDing, indicator voting, a weighted sum relative to a threshold and any combination of the foregoing mathematical correlations.
11. A method as claimed in claim 9, whereby said other signal representative of a physiological variable is selected from the group consisting of blood oxygen saturation, heart rate, skin temperature, blood pressure, breathing sounds and any combination of the foregoing physiological variables.
12. An apparatus for the diagnosis of apneic or hypopneic episodes resulting in arousals, the apparatus comprising: sensor means for obtaining at least two signals from a patient, a first signal representative of a physiological variable and a second signal representative of skin conductance; and means for correlating said obtained signals, one or more coincident changes in said correlated signals being indicative of an arousal associated with an apneic or hypopneic episode.
13. The apparatus as claimed in claim 12, further comprising a memory for storing said signals in a time sequence.
14. A method for the diagnosis of apneic or hypopneic episodes resulting in arousals, the method comprising the steps of: obtaining at least two signals from a patient, a first signal representative of a physiological variable and a second signal representative of skin conductance, storing said signals as a time sequence; following completion of obtaining said signals, correlating said two or more signals; and determining whether a coincident change in said correlated signals is an indication of the occurrence of an arousal associated with an apneic or hypopneic episode.
15. An apparatus for the acquisition of data from a patient from which the diagnosis of apneic or hypopneic episodes resulting in arousals can be made, the apparatus comprising: sensor means for obtaining from the patient two or more signals, a first signal representative of a physiological variable and a second signal representative of skin conductance; and a memory for storing said signals in a time sequence for subsequent correlation.
16. A method for the determination for a patient of an index of sleep quality, the method comprising the steps of: obtaining two or more signals from the patient, each signal representative of a physiological variable; correlating said two or more signals; and recording instances where there is a coincident chance in said correlated signals, the number of instances of coincidence being proportional to said index, wherein one said signal is representative of skin conductance and said step of correlating includes at least said skin conductance signal.
Patent Citations (335)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| USRe35295 | 1996-07-01 | Estes et al. | |
| USRe35339 | 1996-10-01 | Rapoport | |
| US2904033 | 1959-09-01 | Shane | |
| US3099985 | 1963-08-01 | Wilson et al. | |
| US3502100 | 1970-03-01 | Jonson | |
| US3559638 | 1971-02-01 | Potter | |
| US3595228 | 1971-07-01 | Simon et al. | |
| US3611801 | 1971-10-01 | Paine et al. | |
| US3741208 | 1973-06-01 | Jonsson et al. | |
| US3783893 | 1974-01-01 | Davison | |
| US3802417 | 1974-04-01 | Lang | |
| US3817246 | 1974-06-01 | Weigl | |
| US3882847 | 1975-05-01 | Jacobs | |
| US3903875 | 1975-09-01 | Hughes | |
| US3914994 | 1975-10-01 | Banner | |
| US3932054 | 1976-01-01 | McKelvey | |
| US3985467 | 1976-10-01 | Lefferson | |
| US3989037 | 1976-11-01 | Franetzki | |
| US3992598 | 1976-11-01 | Welsh et al. | |
| US3995661 | 1976-12-01 | Van Fossen | |
| US4006634 | 1977-02-01 | Billette et al. | |
| US4083245 | 1978-04-01 | Osborn | |
| US4109749 | 1978-08-01 | Sweet | |
| US4119096 | 1978-10-01 | Drews | |
| US4206754 | 1980-06-01 | Cox et al. | |
| US4249527 | 1981-02-01 | Ko et al. | |
| US4301833 | 1981-11-01 | Donald, III | |
| US4312235 | 1982-01-01 | Daigle | |
| US4320766 | 1982-03-01 | Alihanka et al. | |
| US4322594 | 1982-03-01 | Brisson | |
| US4381788 | 1983-05-01 | Douglas | |
| US4387722 | 1983-06-01 | Kearns | |
| US4396034 | 1983-08-01 | Cherniak | |
| US4414982 | 1983-11-01 | Durkan | |
| US4433693 | 1984-02-01 | Hochstein | |
| US4448058 | 1984-05-01 | Jaffe et al. | |
| US4449525 | 1984-05-01 | White et al. | |
| US4481944 | 1984-11-01 | Bunnell | |
| US4499914 | 1985-02-01 | Schebler | |
| US4506666 | 1985-03-01 | Durkan | |
| US4550615 | 1985-11-01 | Grant | |
| US4550726 | 1985-11-01 | McEwen | |
| US4558710 | 1985-12-01 | Eichler | |
| US4570631 | 1986-02-01 | Durkan | |
| US4576179 | 1986-03-01 | Manus et al. | |
| US4579114 | 1986-04-01 | Gray et al. | |
| US4580575 | 1986-04-01 | Birnbaum et al. | |
| US4592880 | 1986-06-01 | Murakami | |
| US4595016 | 1986-06-01 | Fertig et al. | |
| US4602644 | 1986-07-01 | DiBenedetto et al. | |
| US4630614 | 1986-12-01 | Atlas | |
| US4648396 | 1987-03-01 | Raemer | |
| US4648407 | 1987-03-01 | Sackner | |
| US4655213 | 1987-04-01 | Rapoport et al. | |
| US4677975 | 1987-07-01 | Edgar et al. | |
| US4686974 | 1987-08-01 | Sato et al. | |
| US4686999 | 1987-08-01 | Snyder et al. | |
| US4738266 | 1988-04-01 | Thatcher | |
| US4747403 | 1988-05-01 | Gluck et al. | |
| US4773411 | 1988-09-01 | Downs | |
| US4777963 | 1988-10-01 | McKenna | |
| US4795314 | 1989-01-01 | Prybella et al. | |
| US4802485 | 1989-02-01 | Bowers et al. | |
| US4803471 | 1989-02-01 | Rowland | |
| US4819629 | 1989-04-01 | Jonson | |
| US4823788 | 1989-04-01 | Smith et al. | |
| US4825802 | 1989-05-01 | Le Bec | |
| US4827922 | 1989-05-01 | Champain et al. | |
| US4838258 | 1989-06-01 | Dryden et al. | |
| US4844085 | 1989-07-01 | Gattinoni | |
| US4856506 | 1989-08-01 | Jinotti | |
| US4860766 | 1989-08-01 | Sackner | |
| US4870960 | 1989-10-01 | Hradek | |
| US4870963 | 1989-10-01 | Carter | |
| US4887607 | 1989-12-01 | Beatty | |
| US4913401 | 1990-04-01 | Handke | |
| US4915103 | 1990-04-01 | Visveshwara et al. | |
| US4928684 | 1990-05-01 | Breitenfelder et al. | |
| US4938210 | 1990-07-01 | Shene | |
| US4938212 | 1990-07-01 | Snook et al. | |
| US4944310 | 1990-07-01 | Sullivan | |
| US4957107 | 1990-09-01 | Sipin | |
| US4960118 | 1990-10-01 | Pennock | |
| US4971065 | 1990-11-01 | Pearce | |
| US4972842 | 1990-11-01 | Korten et al. | |
| US4982738 | 1991-01-01 | Griebel | |
| US4986269 | 1991-01-01 | Hakkinen | |
| US4989599 | 1991-02-01 | Carter | |
| US5009635 | 1991-04-01 | Scarberry | |
| US5024219 | 1991-06-01 | Dietz | |
| US5048515 | 1991-09-01 | Sanso | |
| US5052400 | 1991-10-01 | Dietz | |
| US5063922 | 1991-11-01 | Hakkinen | |
| US5065756 | 1991-11-01 | Rapoport | |
| US5069222 | 1991-12-01 | McDonald, Jr. | |
| US5090248 | 1992-02-01 | Cimmino et al. | |
| US5099837 | 1992-03-01 | Russel, Sr. et al. | |
| US5105354 | 1992-04-01 | Nishimura | |
| US5107830 | 1992-04-01 | Younes | |
| US5107831 | 1992-04-01 | Halpern et al. | |
| US5117819 | 1992-06-01 | Servidio et al. | |
| US5129390 | 1992-07-01 | Chopin et al. | |
| US5134995 | 1992-08-01 | Gruenke et al. | |
| US5148802 | 1992-09-01 | Sanders et al. | |
| US5161525 | 1992-11-01 | Kimm et al. | |
| US5161541 | 1992-11-01 | Bowman et al. | |
| US5165398 | 1992-11-01 | Bird | |
| US5170798 | 1992-12-01 | Riker | |
| US5174287 | 1992-12-01 | Kallok et al. | |
| US5178138 | 1993-01-01 | Walstrom et al. | |
| US5183983 | 1993-02-01 | Knop | |
| US5190048 | 1993-03-01 | Wilkinson | |
| US5195528 | 1993-03-01 | Hok | |
| US5199424 | 1993-04-01 | Sullivan et al. | |
| US5203343 | 1993-04-01 | Axe et al. | |
| US5230330 | 1993-07-01 | Price | |
| US5231979 | 1993-08-01 | Rose et al. | |
| US5231983 | 1993-08-01 | Matson et al. | |
| US5233983 | 1993-08-01 | Markowitz | |
| US5239994 | 1993-08-01 | Atkins | |
| US5239995 | 1993-08-01 | Estes et al. | |
| US5245995 | 1993-09-01 | Sullilvan et al. | |
| US5259373 | 1993-11-01 | Gruenke et al. | |
| US5271391 | 1993-12-01 | Graves | |
| US5280784 | 1994-01-01 | Kohler | |
| US5293864 | 1994-03-01 | McFadden | |
| US5295491 | 1994-03-01 | Gevins | |
| US5303698 | 1994-04-01 | Tobia et al. | |
| US5303700 | 1994-04-01 | Weismann et al. | |
| US5305787 | 1994-04-01 | Thygesen | |
| US5311875 | 1994-05-01 | Stasz | |
| US5313937 | 1994-05-01 | Zdrojkowski | |
| US5322057 | 1994-06-01 | Raabe et al. | |
| US5327899 | 1994-07-01 | Harris et al. | |
| US5335654 | 1994-08-01 | Rapoport | |
| US5335656 | 1994-08-01 | Bowe et al. | |
| US5343878 | 1994-09-01 | Scarberry et al. | |
| US5353788 | 1994-10-01 | Miles | |
| US5360008 | 1994-11-01 | Campbell, Jr. | |
| US5373842 | 1994-12-01 | Olsson et al. | |
| US5388571 | 1995-02-01 | Roberts et al. | |
| US5394882 | 1995-03-01 | Mawhinney | |
| US5398673 | 1995-03-01 | Lambert | |
| US5400777 | 1995-03-01 | Olsson et al. | |
| US5404871 | 1995-04-01 | Goodman et al. | |
| US5413111 | 1995-05-01 | Wilkinson | |
| US5433193 | 1995-07-01 | Sanders et al. | |
| US5438980 | 1995-08-01 | Phillips | |
| US5443061 | 1995-08-01 | Champain et al. | |
| US5443075 | 1995-08-01 | Holscher | |
| US5448996 | 1995-09-01 | Bellin et al. | |
| US5458137 | 1995-10-01 | Axe et al. | |
| US5479920 | 1996-01-01 | Piper et al. | |
| US5479939 | 1996-01-01 | Ogino | |
| US5483969 | 1996-01-01 | Testerman et al. | |
| US5490502 | 1996-02-01 | Rapoport et al. | |
| US5492113 | 1996-02-01 | Estes et al. | |
| US5503146 | 1996-04-01 | Froehlich et al. | |
| US5507282 | 1996-04-01 | Younes | |
| US5509404 | 1996-04-01 | Lloyd et al. | |
| US5513631 | 1996-05-01 | McWilliams | |
| US5517983 | 1996-05-01 | Deighan et al. | |
| US5522382 | 1996-06-01 | Sullivan et al. | |
| US5526805 | 1996-06-01 | Lutz et al. | |
| US5535738 | 1996-07-01 | Estes et al. | |
| US5535739 | 1996-07-01 | Rapoport et al. | |
| US5537997 | 1996-07-01 | Mechlenburg et al. | |
| US5540219 | 1996-07-01 | Mechlenburg et al. | |
| US5540220 | 1996-07-01 | Gropper | |
| US5540733 | 1996-07-01 | Testerman et al. | |
| US5546933 | 1996-08-01 | Rapoport et al. | |
| US5546952 | 1996-08-01 | Erickson | |
| US5549106 | 1996-08-01 | Gruenke et al. | |
| US5549655 | 1996-08-01 | Erickson | |
| US5551418 | 1996-09-01 | Estes et al. | |
| US5551419 | 1996-09-01 | Froehlich et al. | |
| US5558099 | 1996-09-01 | Bowman et al. | |
| US5567127 | 1996-10-01 | Wentz | |
| US5570682 | 1996-11-01 | Johnson | |
| US5588439 | 1996-12-01 | Hollub | |
| US5598838 | 1997-02-01 | Servidio et al. | |
| US5605151 | 1997-02-01 | Lynn | |
| US5608647 | 1997-03-01 | Rubsamen et al. | |
| US5617846 | 1997-04-01 | Graetz et al. | |
| US5630411 | 1997-05-01 | Holscher | |
| US5632269 | 1997-05-01 | Zdrojkowski | |
| US5633552 | 1997-05-01 | Lee et al. | |
| US5642730 | 1997-07-01 | Baran | |
| US5645053 | 1997-07-01 | Remmers et al. | |
| US5645054 | 1997-07-01 | Cotner et al. | |
| US5647351 | 1997-07-01 | Wesimann et al. | |
| US5655520 | 1997-08-01 | Howe et al. | |
| US5655522 | 1997-08-01 | Mechlenburg et al. | |
| US5660171 | 1997-08-01 | Kimm et al. | |
| US5666946 | 1997-09-01 | Langenback | |
| US5682878 | 1997-11-01 | Ogden | |
| US5685296 | 1997-11-01 | Zdrojkowski et al. | |
| US5701883 | 1997-12-01 | Hete et al. | |
| US5704345 | 1998-01-01 | Berthon-Jones | |
| US5715812 | 1998-02-01 | Deighan et al. | |
| US5730121 | 1998-03-01 | Hawkins | |
| US5740795 | 1998-04-01 | Brydon | |
| US5794615 | 1998-08-01 | Estes | |
| US5797852 | 1998-08-01 | Karakasoglu et al. | |
| US5803066 | 1998-09-01 | Rapoport et al. | |
| US5823187 | 1998-10-01 | Estes et al. | |
| US5845636 | 1998-12-01 | Gruenke et al. | |
| AUX76019/91 | 1990-06-01 | ||
| AUX62221/90 | 1991-03-01 | ||
| AUX33877/93 | 1993-04-01 | ||
| AUX59270/90 | 1993-05-01 | ||
| AUX38508/93 | 1993-07-01 | ||
| AUX48748/93 | 1993-09-01 | ||
| AUX52628/93 | 1993-12-01 | ||
| AUX52628/93 | 1994-07-01 | ||
| AUX79174/94 | 1995-06-01 | ||
| AUX34471/95 | 1996-02-01 | ||
| AUX40711-95 | 1996-04-01 | ||
| AUX34354/95 | 1996-05-01 | ||
| AUX39130/95 | 1996-06-01 | ||
| AUX42027/97 | 1998-02-01 | ||
| EPX62166A2 | 1982-10-01 | ||
| EPX66451A1 | 1982-12-01 | ||
| EPXB10088761 | 1983-09-01 | ||
| EPX164500 | 1985-03-01 | ||
| EPX171321A1 | 1986-02-01 | ||
| EPX185980 | 1986-07-01 | ||
| EPX236850A2 | 1987-09-01 | ||
| EPX872643A2 | 1988-03-01 | ||
| EPX298367A2 | 1989-01-01 | ||
| EPX425092A1 | 1989-09-01 | ||
| EPX452001A2 | 1990-03-01 | ||
| EPX388525A1 | 1990-09-01 | ||
| EPX461281A1 | 1991-12-01 | ||
| EPX481459A1 | 1992-04-01 | ||
| EPX514744A1 | 1992-11-01 | ||
| EPX549299A2 | 1993-06-01 | ||
| EPX606687A2 | 1994-07-01 | ||
| EPX705615A1 | 1994-09-01 | ||
| EPX651971A1 | 1995-05-01 | ||
| EPX656216A2 | 1995-06-01 | ||
| EPX661071A1 | 1995-07-01 | ||
| EPX178925A2 | 1996-04-01 | ||
| EPX709107A1 | 1996-05-01 | ||
| EPX714670A2 | 1996-06-01 | ||
| EPX765631A2 | 1997-04-01 | ||
| EPX788805A2 | 1997-08-01 | ||
| EPX839545A1 | 1998-05-01 | ||
| FRX2574657A1 | 1986-06-01 | ||
| FRX2672221A1 | 1992-08-01 | ||
| FRX2682042A1 | 1993-04-01 | ||
| DEX459104 | 1928-04-01 | ||
| DEX3015279A1 | 1981-10-01 | ||
| DEX3345067A1 | 1984-06-01 | ||
| DEX3402603A1 | 1985-08-01 | ||
| DEX3537507A1 | 1987-04-01 | ||
| DEX3539073A1 | 1987-05-01 | ||
| DEX4432219C1 | 1996-04-01 | ||
| DEX29612119U1 | 1996-12-01 | ||
| DEX19536632A1 | 1997-03-01 | ||
| JPX54-104369 | 1979-08-01 | ||
| JPX60-212607 | 1985-10-01 | ||
| JPX62-103297 | 1987-04-01 | ||
| JPX63-275352 | 1988-11-01 | ||
| JPX2-173397 | 1988-12-01 | ||
| JPX4-70516 | 1992-03-01 | ||
| JPX6-249742 | 1994-09-01 | ||
| JPX6249741 | 1994-09-01 | ||
| JPX7280609 | 1995-10-01 | ||
| JPX8019610 | 1996-01-01 | ||
| SEX1710064A1 | 1992-02-01 | ||
| SEX467041 | 1992-05-01 | ||
| GBX1432572 | 1976-04-01 | ||
| GBX1444053 | 1976-07-01 | ||
| GBX2077444 | 1981-12-01 | ||
| GBX2147506 | 1985-05-01 | ||
| GBX2164569 | 1986-03-01 | ||
| GBX2166871 | 1986-05-01 | ||
| GBX2205167 | 1988-11-01 | ||
| GBX2221302 | 1990-01-01 | ||
| GBX2254700 | 1992-10-01 | ||
| GBX2261290 | 1993-05-01 | ||
| GBX2271811 | 1994-04-01 | ||
| GBX2294400 | 1996-05-01 | ||
| WOXWO80/01044 | 1980-05-01 | ||
| WOXWO82/03548 | 1982-10-01 | ||
| WOXWO82/03326 | 1982-10-01 | ||
| WOXWO86/05965 | 1986-10-01 | ||
| WOXWO86/06969 | 1986-12-01 | ||
| WOXWO87/02577 | 1987-05-01 | ||
| WOXWO88/10108 | 1988-12-01 | ||
| WOXWO89/09565 | 1989-10-01 | ||
| WOXWO90/09146 | 1990-08-01 | ||
| WOXWO90/14121 | 1990-11-01 | ||
| WOXWO91/12051 | 1991-08-01 | ||
| WOXWO91/19456 | 1991-12-01 | ||
| WOXWO92/11054 | 1992-07-01 | ||
| WOXWO92/15353 | 1992-09-01 | ||
| WOXWo92/22244 | 1992-12-01 | ||
| WOXWO93//08857 | 1993-05-01 | ||
| WOXWO93/09834 | 1993-05-01 | ||
| WOXWO93/21982 | 1993-11-01 | ||
| WOXWO93/24169 | 1993-12-01 | ||
| WOXWO94/04071 | 1994-03-01 | ||
| WOXWO94/16759 | 1994-08-01 | ||
| WOXWO94/20051 | 1994-09-01 | ||
| WOXWO94/20018 | 1994-09-01 | ||
| WOXWO94/23780 | 1994-10-01 | ||
| WOXWO95/32016 | 1995-11-01 | ||
| WOXWO95/34917 | 1995-12-01 | ||
| WOXWO96/16688 | 1996-06-01 | ||
| WOXWO96/32055 | 1996-10-01 | ||
| WOXWO96/36279 | 1996-11-01 | ||
| WOXWO96/41571 | 1996-12-01 | ||
| WOXWO96/40337 | 1996-12-01 | ||
| WOXWO97/02064 | 1997-01-01 | ||
| WOXWO97/05824 | 1997-02-01 | ||
| WOXWO97/10019 | 1997-03-01 | ||
| WOXWO97/10868 | 1997-03-01 | ||
| WOXWO97/14354 | 1997-04-01 | ||
| WOXWO97/18752 | 1997-05-01 | ||
| WOXWO97/15343 | 1997-05-01 | ||
| WOXWO97/20499 | 1997-06-01 | ||
| WOXWO97/22377 | 1997-06-01 | ||
| WOXWO97/28838 | 1997-08-01 | ||
| WOXWO97/41812 | 1997-11-01 | ||
| WOXWO98/06449 | 1998-02-01 | ||
| WOXWO98/25662 | 1998-06-01 | ||
| WOXWO98/35715 | 1998-08-01 | ||
| WOXWO98/36245 | 1998-08-01 | ||
| WOXWO98/36338 | 1998-08-01 | ||
| WOXWO98/33433 | 1998-08-01 | ||
| WOXWO98/47554 | 1998-10-01 | ||
| WOXWO98/52467 | 1998-11-01 | ||
| WOXWO98/57691 | 1998-12-01 |
Non-Patent Literature (42)
- New! Breas PV 100 CPAP First Class Quality and Function. At the right Price; Jul. 4, 1998, pp. 1-2.
- PV 101 Bi Level CPAP and PV 102 Bi-Level Time; pp. 1-3, Dec. 1998.
- Prodigy Medical Supplies Co. Ltd.; CPAP.
- Puritan Bennett; Companion 318 Nasal CPAP System; May 1993.
- Nellcor Puritan Bennett; Announcing the Goodnight 314 and GoodKnight 318 Nasal CPAP Systems, 1996.
- Puritan Bennett; Clean, Quiet, and Comfortable . . . The Companion's 515 Nasal CPAP System; Jun. 1988.
- DeVilbiss Night Guard Nasal CPAP for the Treatment of Obstructive Sleep Apnea.
- Sunrise; DeVilbiss Horizon LT 8001 Nasal CPAP Therapy Small in Size, big features.
- Devilbiss; Revitalizer Soft Start; The Facts Speak for Themselves, 1992.
- Tranquility; Performance CPAP Advantage.
- Healthdyne International; Tranquility Plus.
- Respironics Inc.; Respironics' Solo CPAP System Provides Simplified OSA Therapy at an Outstanding value; Sep. 19, 1996.
- Respironics Inc.; The First Family of OSA Therapy; 1991.
- Fisher & Paykel Healthcare; HC200 Series Nasal CPAP Blower & Heated Humidifier.
- Pierre Medical; Morphee Plus appareil de traitment des apnees du sommeil manuel d'utilisation.
- Weinmann:Hamburg; Somnotron nCPAP-Great WM 2300, Nov. 1991.
- Puritan Bennett; 515a Part of Our Blueprint for the Future; Mar. 1990.
- Puritan Bennett; Companion 320 I/E Bi-Level Respiratory System; Apr. 1993.
- ResMed; Sullivan VPAP II & II ST.
- ResMed; The Sullivan V Family of CPAP Systems.
- ResMed; The AutoSet Portable II.
- ResMed; Sullivan Nasal CPAP System.
- ResMed; The Sullivan IIID.
- ResMed; The Sullivan Comfort.
- DeVilbiss a Division of Sunrise Medical; Expand your Horizons With The Horizons, 1995.
- Healthdyne Technologies; Home Health Care Dealer; The Journal of Home Medical Equipment and Services/Supplier; Nov. and Dec. 1997.
- Healthdyne International; Tranquility Quest, The Compact CPAP for Greater patient comfort.
- AirSep; Medical Products . . . Stand the Test of Time.
- MAP Medical Progress for Physician und Patient; The Gentle Therapy for Sleep-Related Breathing Disorders.
- Taema; Ventilation CP 90.
- DPAP; Breath, by breath, by breath.
- Lifecare; Smallest. Quietest. Smartest.
- Lifecare; Quiet CPAP System for Maximum Compliance; 1991.
- Lifecare; Software Nasal Mask, Custom Nasal Masks; 1991.
- Nidek Medical; Silenzio.
- Weinmann; Just to Fell Well, Sensitive Sleep Apnoea Therapy with Somnotron 3 and Somno-Mask System.
- Respironics Inc.; Aria CPAP System.
- Respironics Inc.; SleepEasy III A New Dawn in Patient Compliance.
- Respironics Inc.; Multiple Choice REMstar Choice Nasal CPAP System, 1993.
- Maxll nCPAP and Moritz II Bi-Level Brochure.
- Derwent: Flowmeter for fluids--has turbine transducer and volumetric sensor for simultaneous calibration, May 1994.
- Mark Kantrowitz, Erik Horskotte and Cliff Joslyn; "Answers to Frequently Asked Questions about Fuzzy Logic and Fuzzy Expert Systems" Version 1.24 last Modified Feb. 20, 1996.